Doris Stoermer

544 total citations
11 papers, 484 citations indexed

About

Doris Stoermer is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Doris Stoermer has authored 11 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Cellular and Molecular Neuroscience and 3 papers in Pharmacology. Recurrent topics in Doris Stoermer's work include Neuropeptides and Animal Physiology (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Plant biochemistry and biosynthesis (3 papers). Doris Stoermer is often cited by papers focused on Neuropeptides and Animal Physiology (4 papers), Cholinesterase and Neurodegenerative Diseases (3 papers) and Plant biochemistry and biosynthesis (3 papers). Doris Stoermer collaborates with scholars based in United States and Netherlands. Doris Stoermer's co-authors include Clayton H. Heathcock, Stéphane Caron, Barbara S. Slusher, Takashi Tsukamoto, Krystyna M. Wozniak, Anna K. Mapp, Paul Jackson, Weixing Li, Camilo Rojas and Greg Delahanty and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Doris Stoermer

11 papers receiving 466 citations

Peers

Doris Stoermer
Samir Saleh United States
Bridget Duvall United States
Niyada Hin United States
Marc Gerspacher Switzerland
Christopher M. Tegley United States
Mingde Xia United States
Samir Saleh United States
Doris Stoermer
Citations per year, relative to Doris Stoermer Doris Stoermer (= 1×) peers Samir Saleh

Countries citing papers authored by Doris Stoermer

Since Specialization
Citations

This map shows the geographic impact of Doris Stoermer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Stoermer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Stoermer more than expected).

Fields of papers citing papers by Doris Stoermer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Stoermer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Stoermer. The network helps show where Doris Stoermer may publish in the future.

Co-authorship network of co-authors of Doris Stoermer

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Stoermer. A scholar is included among the top collaborators of Doris Stoermer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Stoermer. Doris Stoermer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Stoermer, Doris, Dilrukshi Vitharana, Niyada Hin, et al.. (2012). Design, Synthesis, and Pharmacological Evaluation of Glutamate Carboxypeptidase II (GCPII) Inhibitors Based on Thioalkylbenzoic Acid Scaffolds. Journal of Medicinal Chemistry. 55(12). 5922–5932. 24 indexed citations
2.
Majer, Pavel, Doris Stoermer, Weizheng Xu, et al.. (2006). Structural Optimization of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II by Modification of the P1‘ Side Chain. Journal of Medicinal Chemistry. 49(10). 2876–2885. 35 indexed citations
3.
Mathews, William B., Catherine A. Foss, Doris Stoermer, et al.. (2005). Synthesis and biodistribution of (11)C-GW7845, a positron-emitting agonist for peroxisome proliferator-activated receptor-{gamma}.. PubMed. 46(10). 1719–26. 6 indexed citations
4.
Stoermer, Doris, Qun Liu, Ajit G. Thomas, et al.. (2003). Synthesis and biological evaluation of hydroxamate-Based inhibitors of glutamate carboxypeptidase II. Bioorganic & Medicinal Chemistry Letters. 13(13). 2097–2100. 40 indexed citations
5.
Majer, Pavel, Paul Jackson, Greg Delahanty, et al.. (2003). Synthesis and Biological Evaluation of Thiol-Based Inhibitors of Glutamate Carboxypeptidase II:  Discovery of an Orally Active GCP II Inhibitor. Journal of Medicinal Chemistry. 46(10). 1989–1996. 91 indexed citations
6.
Jackson, Paul, Weixing Li, Takashi Tsukamoto, et al.. (2001). Design and Pharmacological Activity of Phosphinic Acid Based NAALADase Inhibitors. Journal of Medicinal Chemistry. 44(24). 4170–4175. 83 indexed citations
7.
Stoermer, Doris, et al.. (2000). Calicheamicin−Homeodomain Conjugate as an Efficient, Sequence-Specific DNA Cleavage and Mapping Tool. Journal of the American Chemical Society. 122(51). 12884–12885. 11 indexed citations
8.
Stoermer, Doris, Stéphane Caron, & Clayton H. Heathcock. (1997). ChemInform Abstract: Total Synthesis of Zaragozic Acid A (Squalestatin S1) (I). Degradation to a Relay Compound (II) and Reassembly of the Natural Product.. ChemInform. 28(18). 1 indexed citations
9.
Caron, Stéphane, Doris Stoermer, Anna K. Mapp, & Clayton H. Heathcock. (1996). Total Synthesis of Zaragozic Acid A (Squalestatin S1). Synthesis of the Relay Compound. The Journal of Organic Chemistry. 61(26). 9126–9134. 55 indexed citations
10.
Stoermer, Doris, Stéphane Caron, & Clayton H. Heathcock. (1996). Total Synthesis of Zaragozic Acid A (Squalestatin S1). Degradation to a Relay Compound and Reassembly of the Natural Product. The Journal of Organic Chemistry. 61(26). 9115–9125. 58 indexed citations
11.
Stoermer, Doris & Clayton H. Heathcock. (1993). Total synthesis of (-)-alloaristoteline, (-)-serratoline, and (+)-aristotelone. The Journal of Organic Chemistry. 58(3). 564–568. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026